^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    BOS-342

    i
    Other names: BOS-342, PRS-342, lipocalin variant, PRS 342, MPAL1073
    Associations
    News
    Trials
    Company:
    Boston Pharma, Pieris Pharmaceuticals
    Drug class:
    CD137 agonist, GPC-3 inhibitor
    Related drugs:
    Associations
    News
    Trials